Endogene Synthese kurzlebiger Messenger-RNS in der Oocyte vonDysdercus intermedius Dist. nach Abschluß der Vitellogenese

Zusammenfassung In den Oocyten des telotroph-meroistischen Ovars vonDysdercus intermedius Dist. findet während der Endphase der Oogenese, 4–14 h vor der Eiablage, eine Synthese von nichtribosomaler RNS statt. Eine in vivo-Markierung dieser RNS läßt sich erreichen, wenn radioaktive RNS-Vorstufen einem Nucleotidpool zugeführt werden, der im Ooplasma vor der Chorionbildung angelegt wird.Diese vor der Eiablage gebildete RNS zeichnet sich durch einen hohen Turnover aus. Sie erscheint zunächst in Form einer hochmolekularen Vorstufe und wird im Verlauf weniger Stunden in kleinere, nichtribosomale Moleküle mit S-Werten zwischen 30 und 5 umgewandelt. Im frisch abgelegten Ei fehlen RNS-Spezies, die dieser endogenen Oocytensynthese entstammen; es sind nur noch ihre Degradationsprodukte, die sich innerhalb der Nucleotidfraktion ansammeln, nachweisbar. Die endogen synthetisierte RNS wird demnach im Gegensatz zu der in den Nährzellen synthetisierten und im Ei in stabiler Form gespeicherten RNS nicht für einen Bedarf während der Embryogenese konserviert.Die endogen synthetisierte RNS zeichnet sich durch einen hohen Poly (A)-Gehalt aus; 57% hybridisieren mit an Glasfaserfiltern immobilisiertem Poly(U). Wenige Stunden vor der Eiablage findet man kurzlebige oocytäre RNS-Moleküle an Polysomen assoziiert. Die Inkubation dieser Polysomen in einem in vitro-Proteinsynthese-System liefert Polypeptide, deren Auftrennung am SDS-Polyacrylamid-Gel ein charakteristisches Bandenspektrum ergibt. Die Molekulargewichte der 4 Hauptbanden liegen bei 65000, 48000, 44000, und 40000. Keines dieser Proteine ist mit einem Chorionprotein identisch.Die Kurzlebigkeit, der relativ hohe Poly (A)-Gehalt sowie die Fähigkeit, die Proteinsynthese sowohl in vivo als auch in vitro zu aktivieren, spricht dafür, daß die spät-oocytär gebildete heterogene Population von RNS-Molekülen mRNS-Komponenten enthält.Bei Frl. Heidrun Greipel bedanken wir uns für die ausgezeichnète Assistenz.     

An inhibition enzyme immunoassay for myelin basic protein

An improved Enzyme Immunoassay for Myelin Basic Protein is described. Myelin Basic Protein covalently attached to glass balls, and Myelin Basic Protein in samples compete with each other for binding of a peroxidase conjugated anti Myelin Basic Protein antibody. The peroxidase activity on the balls is then inversely proportional to the amount of Myelin Basic Protein in the sample. A detection limit of 0.6 ng/ml is demonstrated for diluent or spinal fluid. For plasma a dilution step increases this to 1.8 ng/ml. Both the coated balls and the peroxidase conjugate are stable for long periods. The assay requires no expensive equipment. Although the assay appears to be valid for subcellular fractions spinal fluid and plasma, successful detection of Myelin Basic Protection peptides in clinical samples may require careful selection of suitable antisera. The assay would be very suitable for eventual use with an appropriate monoclonal antibody.     

Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG.

Cellular receptors for IgG (Fc gamma R) mediate important protective functions. By using site-specific mutants of a chimeric antibody (mouse V H domain and L chain; human IgG3 C H domains), we have demonstrated that human Fc gamma RI interacts with a site in the lower hinge of human IgG (residues 234 to 237) and that this interaction dictates Fc gamma RI-mediated superoxide generation. Mutations at position 235 resulted in the most profound reductions in Fc gamma RI recognition. We have also mapped an interaction site for Fc gamma RII to the same region; however, mutations at position 234 and 237 resulted in the greatest reductions in Fc gamma RII recognition. The two receptors appear to recognize overlapping but nonidentical sites on the lower hinge of IgG. Deviations from the optimal motif 234-Leu-Leu-Gly-Gly-237 may then explain the human IgG subclass specificity profile for human Fc gamma RI and Fc gamma RII.     

Structural repertoire of the human VH segments.

The VH gene segments produce the part of the VH domains of antibodies that contains the first two hypervariable regions. The sequences of 83 human VH segments with open reading frames, from several individuals, are currently known. It has been shown that these sequences are likely to form a high proportion of the total human repertoire and that an individual's gene repertoire produces about 50 VH segments with different protein sequences. In this paper we present a structural analysis of the amino acid sequences produced by the 83 segments. Particular residue patterns in the sequences of V domains imply particular main-chain conformations, canonical structures, for the hypervariable regions. We show that, in almost all cases, the residue patterns in the VH segments imply that the first hypervariable regions have one of three different canonical structures and that the second hypervariable regions have one of five different canonical structures. The different observed combinations of the canonical structures in the first and second regions means that almost all sequences have one of seven main-chain folds. We describe, in outline, structures of the antigen binding site loops produced by nearly all the VH segments. The exact specificity of the loops is produced by (1) sequence differences in their surface residues, particularly at sites near the centre of the combining site, and (2) sequence differences in the hypervariable and framework regions that modulate the relative positions of the loops.     

Molecular basis of apparent isolated 17,20-lyase deficiency: compound heterozygous mutations in the C-terminal region (Arg(496)----Cys, Gln(461)----Stop) actually cause combined 17 alpha-hydroxylase/17,20-lyase deficiency.

The molecular defect in a reported case of isolated 17,20-lyase deficiency in a 46XY individual has been elucidated. The patient was found to be a compound heterozygote, carrying two different mutant alleles in the CYP17 gene. One allele contains a point mutation of arginine (CGC) to cysteine (TGC) at amino acid 496 in exon 8. The second allele contains a stop codon (TAG) in place of glutamine (CAG) at position 461 in exon 8 which is located 19 amino acids to the carboxy-terminal side of the P-450(17) alpha heme binding cysteine. COS-1 cells transfected with cDNAs containing one or the other of these mutations showed dramatically reduced 17 alpha-hydroxylase and 17,20-lyase activities relative to cells transfected with the wild type P-450(17) alpha cDNA. While the in vitro data in COS 1 cells can explain the patient's physical phenotype, with female external genitalia, it was somewhat discordant with the clinical expression of isolated 17,20-lyase deficiency with relative preservation of 17 alpha-hydroxylase activity in vivo. In addition to the expression studies of these two examples of mutants in the C-terminal region of cytochrome P-450(17) alpha, a third mutant cDNA construct containing a 4-base duplication at codon 480 previously found in patients with combined 17 alpha-hydroxylase/17,20-lyase deficiency was also expressed in COS-1 cells. This expressed protein was completely inactive with respect to both activities, supporting the biochemical findings in serum and in vitro biochemical data obtained using a testis from the patient. The results from these patients clearly indicate the importance of the C-terminal region of human P-450(17) alpha in its enzymatic activities.